louisiana semaglutide stomach paralysis law firm glp-1 digestive blockage attorney gastric intestinal obstruction in GLP-1 Medication Lawyer in Georgia-mvanhaasteren.nl louisiana glp-1 lawyer – louisiana semaglutide gastric intestinal obstruction

Open assessment report (PDF)

Semaglutide (Wegovy) is approved for chronic weight management in adults and adolescents aged 12 years and older with an initial BMI at or above the 95th percentile for age and sex

January 6, 2026: The GLP-1 MDL, which includes claims for people alleging harm after taking Mounjaro, now has over 3,000 cases pending

trial 2: N = 32) demonstrated that there were no clinically relevant effects of oral semaglutide (20 mg) on the plasma concentration-time curve (AUC) and maximum plasma concentration ( C max ) for the antihypertensive drug lisinopril (20 mg single dose [trial 1]), the anticoagulant agent warfarin (25 mg single dose [trial 1]), or digoxin (500 g [trial 2]) [42]